agilon health (NYSE:AGL) Downgraded by JMP Securities to Market Perform

JMP Securities lowered shares of agilon health (NYSE:AGL) from an outperform rating to a market perform rating in a research report released on Monday morning, Marketbeat.com reports.

Several other equities analysts have also recently issued reports on the stock. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Citigroup reiterated a “sell” rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Evercore ISI cut their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $6.38.

agilon health Trading Down 8.5 %

NYSE AGL opened at $1.72 on Monday. The firm has a 50 day simple moving average of $3.14 and a 200-day simple moving average of $4.90. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a one year low of $1.70 and a one year high of $13.76. The firm has a market cap of $708.67 million, a price-to-earnings ratio of -2.01 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the business posted ($0.06) EPS. Equities research analysts anticipate that agilon health will post -0.35 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 3.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On agilon health

Institutional investors and hedge funds have recently bought and sold shares of the business. Quantbot Technologies LP bought a new stake in shares of agilon health in the 1st quarter valued at approximately $862,000. Swiss National Bank lifted its holdings in shares of agilon health by 0.6% during the first quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after buying an additional 3,400 shares during the last quarter. Bleakley Financial Group LLC acquired a new position in shares of agilon health in the first quarter valued at $65,000. Blair William & Co. IL grew its position in agilon health by 8.3% in the first quarter. Blair William & Co. IL now owns 242,076 shares of the company’s stock valued at $1,477,000 after acquiring an additional 18,599 shares during the period. Finally, Vanguard Group Inc. grew its position in agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.